Bayer stock fell 1.01 percent as Ohio plan adds USD 2.2 billion

Published on 10/03/2026 at 23:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Bayer stock was last at EUR 44.94 on Xetra on October 2, 2026, 16.65 percent below its 52-week high. Volume reached 2,695,162 shares.

Flaches Vintage-Grafikposter im Bauhaus-Stil: LEVERKUSEN als fette Überschrift, SEIT 1863 als Subline, zentrales hexagonales Molekülmotiv in Rot-Schwarz-Gold, Industrie- und Brückensilhouetten — Bauhaus-Retro-Poster mit Text LEVERKUSEN / SEIT 1863, geometrischem Benzolring-Motiv und Industrie-Silhouetten, Illustration mit AI erstellt.

Bayer stock (ISIN DE000BAY0017) was last at EUR 44.94 on Xetra on October 2, 2026 at 5:35 p.m. CEST, down 1.01 percent for the session. The move came as Bayer announced a USD 2.2 billion pharmaceutical manufacturing site in Ohio, giving the market a major long-term investment figure to weigh against near-term share-price pressure.

Ohio investment sets a long horizon

According to Bayer on October 2, 2026, the New Albany site will initially support oncology, cardiovascular and renal medicines. The first drug-substance module is expected to become operational in 2031, while a second module for finished products is planned for 2034.

The project extends Bayer's US manufacturing footprint and follows more than USD 7 billion in US pharmaceutical research and manufacturing spending over the past five years, according to Bayer. That timing matters: the first production capacity is scheduled several years ahead, so the announcement supports strategic positioning rather than immediate earnings.

Analyst targets stay above the quote

Barclays raised its Bayer target from EUR 60 to EUR 70 and retained an Overweight rating on September 8, 2026, according to Finanznachrichten. Deutsche Bank Research retained a Buy rating and a EUR 60 target on September 10, 2026, as reported by Finanznachrichten.

The higher Barclays target stands EUR 25.06 above the October 2 quote, while the Deutsche Bank target is EUR 15.06 higher. The gap shows that analyst expectations remain materially above the latest Xetra price, even as the stock's next operational milestones sit years away.

Bayer stock remains below its yearly high

Bayer's EUR 25.78 to EUR 53.92 52-week range places the EUR 44.94 quote 16.65 percent below the yearly high. Market capitalization stood at EUR 44.2 billion and trading volume reached 2,695,162 shares on October 2, 2026, giving the Ohio announcement a market context shaped by a 1.01 percent daily decline.